BUSINESS● LOW3d ago · Oct 23, 2026, 11:10 PM
Dr. Reddy’s outlines semaglutide relaunch in November 2026 and reiterates 6M-7M devices target
Seeking Alpha Tech · global
Dr. Reddy's has announced plans to relaunch semaglutide in November 2026 and reaffirmed its target of 6-7 million devices. This indicates a future business strategy and production goal for the company.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS14m agoMicrosoft offers voluntary exit packages to 60,000 staff, with some Indian teams eligibleThe HinduBUSINESS43m agoCadence raises 2026 outlook to 21% revenue growth and $8.40 non-GAAP EPS as it launches Maestro modelsSeeking Alpha Tech